JP2004536857A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2004536857A5 JP2004536857A5 JP2003513564A JP2003513564A JP2004536857A5 JP 2004536857 A5 JP2004536857 A5 JP 2004536857A5 JP 2003513564 A JP2003513564 A JP 2003513564A JP 2003513564 A JP2003513564 A JP 2003513564A JP 2004536857 A5 JP2004536857 A5 JP 2004536857A5
- Authority
- JP
- Japan
- Prior art keywords
- oil
- group
- use according
- composition
- cancer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- -1 methylcyclohexyl Chemical group 0.000 claims 12
- 239000000203 mixture Substances 0.000 claims 12
- 239000003921 oil Substances 0.000 claims 9
- 235000019198 oils Nutrition 0.000 claims 9
- 150000002632 lipids Chemical class 0.000 claims 7
- 206010028980 Neoplasm Diseases 0.000 claims 6
- 125000005843 halogen group Chemical group 0.000 claims 5
- 235000014113 dietary fatty acids Nutrition 0.000 claims 4
- 239000000194 fatty acid Substances 0.000 claims 4
- 229930195729 fatty acid Natural products 0.000 claims 4
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims 4
- 210000004185 liver Anatomy 0.000 claims 4
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 3
- 229910052739 hydrogen Inorganic materials 0.000 claims 3
- 239000001257 hydrogen Substances 0.000 claims 3
- 125000005936 piperidyl group Chemical group 0.000 claims 3
- 125000006273 (C1-C3) alkyl group Chemical group 0.000 claims 2
- LDVVTQMJQSCDMK-UHFFFAOYSA-N 1,3-dihydroxypropan-2-yl formate Chemical compound OCC(CO)OC=O LDVVTQMJQSCDMK-UHFFFAOYSA-N 0.000 claims 2
- 235000019483 Peanut oil Nutrition 0.000 claims 2
- 235000019498 Walnut oil Nutrition 0.000 claims 2
- 210000001367 artery Anatomy 0.000 claims 2
- WDQPAMHFFCXSNU-BGABXYSRSA-N clofazimine Chemical compound C12=CC=CC=C2N=C2C=C(NC=3C=CC(Cl)=CC=3)C(=N/C(C)C)/C=C2N1C1=CC=C(Cl)C=C1 WDQPAMHFFCXSNU-BGABXYSRSA-N 0.000 claims 2
- 229960004287 clofazimine Drugs 0.000 claims 2
- 150000001875 compounds Chemical class 0.000 claims 2
- 125000000753 cycloalkyl group Chemical group 0.000 claims 2
- FMMOOAYVCKXGMF-MURFETPASA-N ethyl linoleate Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(=O)OCC FMMOOAYVCKXGMF-MURFETPASA-N 0.000 claims 2
- 229940031016 ethyl linoleate Drugs 0.000 claims 2
- 150000004665 fatty acids Chemical class 0.000 claims 2
- 125000004785 fluoromethoxy group Chemical group [H]C([H])(F)O* 0.000 claims 2
- FMMOOAYVCKXGMF-UHFFFAOYSA-N linoleic acid ethyl ester Natural products CCCCCC=CCC=CCCCCCCCC(=O)OCC FMMOOAYVCKXGMF-UHFFFAOYSA-N 0.000 claims 2
- 239000004006 olive oil Substances 0.000 claims 2
- 235000008390 olive oil Nutrition 0.000 claims 2
- 239000000312 peanut oil Substances 0.000 claims 2
- 239000008194 pharmaceutical composition Substances 0.000 claims 2
- 239000003549 soybean oil Substances 0.000 claims 2
- 235000012424 soybean oil Nutrition 0.000 claims 2
- 150000003626 triacylglycerols Chemical class 0.000 claims 2
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims 2
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 claims 2
- 239000008170 walnut oil Substances 0.000 claims 2
- 206010006187 Breast cancer Diseases 0.000 claims 1
- 208000026310 Breast neoplasm Diseases 0.000 claims 1
- 206010009944 Colon cancer Diseases 0.000 claims 1
- 208000001333 Colorectal Neoplasms Diseases 0.000 claims 1
- 208000008839 Kidney Neoplasms Diseases 0.000 claims 1
- 206010058467 Lung neoplasm malignant Diseases 0.000 claims 1
- 206010027476 Metastases Diseases 0.000 claims 1
- 206010061902 Pancreatic neoplasm Diseases 0.000 claims 1
- 206010060862 Prostate cancer Diseases 0.000 claims 1
- 208000000236 Prostatic Neoplasms Diseases 0.000 claims 1
- 206010038389 Renal cancer Diseases 0.000 claims 1
- 125000004981 cycloalkylmethyl group Chemical group 0.000 claims 1
- 238000001802 infusion Methods 0.000 claims 1
- 201000010982 kidney cancer Diseases 0.000 claims 1
- 201000007270 liver cancer Diseases 0.000 claims 1
- 208000014018 liver neoplasm Diseases 0.000 claims 1
- 201000005202 lung cancer Diseases 0.000 claims 1
- 208000020816 lung neoplasm Diseases 0.000 claims 1
- 208000015486 malignant pancreatic neoplasm Diseases 0.000 claims 1
- 239000002207 metabolite Substances 0.000 claims 1
- 230000009401 metastasis Effects 0.000 claims 1
- 210000000056 organ Anatomy 0.000 claims 1
- 201000002528 pancreatic cancer Diseases 0.000 claims 1
- 208000008443 pancreatic carcinoma Diseases 0.000 claims 1
- 208000011571 secondary malignant neoplasm Diseases 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AUPR6443A AUPR644301A0 (en) | 2001-07-17 | 2001-07-17 | Method and composition for treatment of cancer |
| PCT/AU2002/000954 WO2003007957A1 (en) | 2001-07-17 | 2002-07-16 | Method and composition for treatment of cancer |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2004536857A JP2004536857A (ja) | 2004-12-09 |
| JP2004536857A5 true JP2004536857A5 (enExample) | 2006-01-05 |
Family
ID=3830401
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003513564A Withdrawn JP2004536857A (ja) | 2001-07-17 | 2002-07-16 | 癌の治療のための方法及び組成物 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20040067952A1 (enExample) |
| EP (1) | EP1423118A4 (enExample) |
| JP (1) | JP2004536857A (enExample) |
| KR (1) | KR20040038984A (enExample) |
| CN (1) | CN1551771A (enExample) |
| AU (1) | AUPR644301A0 (enExample) |
| BR (1) | BR0211436A (enExample) |
| CA (1) | CA2453993A1 (enExample) |
| MX (1) | MXPA04000518A (enExample) |
| WO (1) | WO2003007957A1 (enExample) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4763681B2 (ja) * | 2004-03-05 | 2011-08-31 | ベニテック インコーポレイテッド | ＲＮＡｉ作用媒介物の同時デリバリーのためのマルチプロモーター発現カセット |
| EP2200613B1 (en) | 2007-09-21 | 2018-09-05 | The Johns Hopkins University | Phenazine derivatives and uses thereof |
| KR20140051555A (ko) * | 2012-10-23 | 2014-05-02 | 씨지케이바이오 주식회사 | 전립선암 예방 및 치료용 약학 조성물 |
| CN103360329B (zh) * | 2013-07-18 | 2015-11-18 | 中国科学院南海海洋研究所 | 一类吩嗪化合物及其在制备抗肿瘤药物中的应用 |
| BR112018003232A2 (pt) * | 2015-10-06 | 2018-09-25 | Redhill Biopharma Ltd | terapias de combinação para tratamento de câncer |
| WO2019060409A1 (en) * | 2017-09-19 | 2019-03-28 | The Cleveland Clinic Foundation | INHIBITION OF CONNEXIN 46 TO TREAT A GLIOBLASTOMA AND OTHER STATES |
| CN119564691A (zh) * | 2024-12-13 | 2025-03-07 | 首都医科大学附属北京佑安医院 | 氯法齐明在制备治疗癌症的药物中的应用 |
| CN119700770A (zh) * | 2025-01-09 | 2025-03-28 | 首都医科大学附属北京佑安医院 | 氯法齐明在制备修复肠黏膜或改善肠道菌群药物中的应用 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR3658M (fr) * | 1964-02-18 | 1965-11-02 | Michel Marie Andre Guerbet | Composition huileuse pour l'injection intravasculaire. |
| US4578391A (en) * | 1982-01-20 | 1986-03-25 | Yamanouchi Pharmaceutical Co., Ltd. | Oily compositions of antitumor drugs |
| JPS6296A (ja) * | 1985-03-06 | 1987-01-06 | Sumitomo Pharmaceut Co Ltd | 脂溶性白金（２）錯体 |
| EP0280741B1 (en) * | 1986-08-29 | 1994-12-07 | Kyowa Hakko Kogyo Kabushiki Kaisha | Mitomycin derivatives |
| ZA928419B (en) * | 1991-11-29 | 1994-03-01 | Univ Pretoria | Pharmaceutical substances or compositions and their use |
| US5763443A (en) * | 1994-04-05 | 1998-06-09 | Universiteit Van Pretoria | MDR resistance treatment and novel pharmaceutically active riminophenazines |
| DE69528103T2 (de) * | 1994-04-05 | 2003-05-15 | Universiteit Van Pretoria, Gauteng | Verwendung von Riminophenazin zur Behandlung von MDR-Resistenz |
| DE19843223A1 (de) * | 1998-09-22 | 2000-03-30 | Hassan Jomaa | Phosphororganische Verbindungen und ihre Verwendung |
| AUPP332898A0 (en) * | 1998-05-04 | 1998-05-28 | Unisearch Limited | Pharmaceutical composition |
-
2001
- 2001-07-17 AU AUPR6443A patent/AUPR644301A0/en not_active Abandoned
-
2002
- 2002-07-16 CA CA002453993A patent/CA2453993A1/en not_active Abandoned
- 2002-07-16 KR KR10-2004-7000795A patent/KR20040038984A/ko not_active Withdrawn
- 2002-07-16 JP JP2003513564A patent/JP2004536857A/ja not_active Withdrawn
- 2002-07-16 EP EP02748440A patent/EP1423118A4/en not_active Withdrawn
- 2002-07-16 MX MXPA04000518A patent/MXPA04000518A/es unknown
- 2002-07-16 WO PCT/AU2002/000954 patent/WO2003007957A1/en not_active Ceased
- 2002-07-16 CN CNA028157109A patent/CN1551771A/zh active Pending
- 2002-07-16 US US10/467,618 patent/US20040067952A1/en not_active Abandoned
- 2002-07-16 BR BR0211436-4A patent/BR0211436A/pt not_active IP Right Cessation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR102008635B1 (ko) | 영상화제의 합성 및 사용을 위한 조성물, 방법 및 시스템 | |
| JP2005500300A5 (enExample) | ||
| JP2007511504A5 (enExample) | ||
| RU2000127751A (ru) | Противоопухолевое средство | |
| JP2002540208A5 (enExample) | ||
| JP2015512943A5 (enExample) | ||
| RU2014115847A (ru) | Пирролопиримидиновые соединения для лечения злокачественной опухоли | |
| JPWO2021069705A5 (enExample) | ||
| JP2009538336A5 (enExample) | ||
| JP2009530392A5 (enExample) | ||
| JP2004517843A5 (enExample) | ||
| JP2004536857A5 (enExample) | ||
| JP2007523177A5 (enExample) | ||
| RU2002134754A (ru) | Аналоги жирных кислот для лечения рака | |
| JP2012522841A5 (enExample) | ||
| JP2009502777A5 (enExample) | ||
| RU2020143060A (ru) | Антагонисты рецепторов соматостатина и способы их применения | |
| RU2010154417A (ru) | Комбинация частичного агониста никотиновых рецепторов и ингибитора ацетилхолинетеразы, содержащая ее фармацетическая композиция, и ее применение в лечении когнитивных расстройств | |
| JP2013504590A5 (enExample) | ||
| RU2012114146A (ru) | Нерадиоактивные фосфолипидные соединения, композиции и способы их применения | |
| JP2008528617A5 (enExample) | ||
| RU2002105374A (ru) | Сочетанная терапия с использованием пентафторбензолсульфонамидов | |
| US9376432B2 (en) | Use of VEGFR-3 inhibitors for treating hepatocellular carcinoma | |
| ES2898708T3 (es) | Ligandos macrocíclicos lipófilos, sus complejos, así como sus usos médicos | |
| JP2011500841A5 (enExample) |